Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 2,097,500 | 2,072,600 | 1,984,100 | 1,793,400 | 1,724,300 |
| Cost of Goods | 245,800 | 247,400 | 236,500 | 228,000 | 192,300 |
| Gross Profit | 1,851,700 | 1,825,200 | 1,747,600 | 1,565,400 | 1,532,000 |
| Operating Expenses | 811,600 | 947,900 | 693,600 | 1,603,300 | 644,500 |
| Operating Income | 1,040,900 | 877,700 | 1,054,500 | -37,900 | 887,800 |
| Interest Expense | 14,900 | 15,100 | 15,200 | 15,500 | 15,700 |
| Other Income | -71,200 | 8,300 | 43,500 | 9,200 | -51,200 |
| Pre-tax Income | 954,800 | 870,900 | 1,082,800 | -44,200 | 820,900 |
| Income Tax | 192,700 | 100,800 | 230,900 | -111,200 | 167,800 |
| Net Income Continuous | 762,100 | 770,100 | 851,900 | 67,000 | 653,100 |
| Net Income | $762,100 | $770,100 | $851,900 | $67,000 | $653,100 |
| EPS Basic Total Ops | 2.99 | 3.01 | 3.30 | 0.26 | 2.52 |
| EPS Basic Continuous Ops | 2.99 | 3.01 | 3.30 | 0.26 | 2.52 |
| EPS Diluted Total Ops | 2.96 | 2.98 | 3.28 | 0.26 | 2.49 |
| EPS Diluted Continuous Ops | 2.96 | 2.98 | 3.28 | 0.26 | 2.49 |
| EBITDA(a) | $1,076,800 | $911,500 | $1,086,200 | $-6,600 | $916,600 |